STOCK TITAN

Labcorp Holdings (NYSE: LH) CAO sells 1,420 shares after exercising options

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Labcorp Holdings Inc. senior vice president and chief accounting officer Peter J. Wilkinson exercised 1,338 non-qualified stock options at an exercise price of $209.25 per share, receiving 1,338 common shares. On the same date he sold 1,420 common shares in open-market transactions at prices of $309.22 and $309.2311 per share. The specific option grant, issued under Labcorp's Amended and Restated 2016 Omnibus Incentive Plan, is now fully exercised.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Wilkinson Peter J
Role SVP, Chief Accounting Officer
Sold 1,420 shs ($439K)
Approx. gross sale proceeds $439K
Approx. exercise cost $280K
Type Security Shares Price Value
Exercise Non-qualified Stock Options F1, F2, F3 1,338 $0.00 $0.00
Sale Common Stock 82 $309.22 $25K
Exercise Common Stock 1,338 $209.25 $280K
Sale Common Stock 1,338 $309.2311 $414K
Holdings After Transaction: Non-qualified Stock Options — 0 shares (Direct); Common Stock — 1,770.2194 shares (Direct)
Footnotes (3)
  1. F1. Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
  2. F2. Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
  3. F3. The options vested in three equal annual installments beginning on the date reflected in this column and are now fully exercisable.
Options exercised 1,338 shares Non-qualified stock options exercised into common stock on 2026-08-03
Exercise price $209.25 per share Conversion or exercise price of the non-qualified stock options
Common shares sold 1,338 shares Open-market sale at $309.2311 per share on 2026-08-03
Additional shares sold 82 shares Open-market sale at $309.22 per share on 2026-08-03
Net shares sold 1,420 shares Net of all buy and sell transactions reported for 2026-08-03
Option expiration date 2031-02-01 Original expiration date of the exercised non-qualified stock options
Non-qualified Stock Options financial
"security_title: Non-qualified Stock Options"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Amended and Restated 2016 Omnibus Incentive Plan financial
"granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan"
spin-off financial
"applied to equity awards in connection with the spin-off of Fortrea Holdings Inc."
A spin-off happens when a company creates a new, independent business by separating part of itself, like splitting off a division into its own company. This often happens so the new company can focus better on its own goals or attract different investors. It matters because it can lead to more growth opportunities and clearer focus for both companies.
Employee Matters Agreement regulatory
"calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider stock transactions did Labcorp Holdings (LH) executive Peter J. Wilkinson report?

Peter J. Wilkinson exercised 1,338 stock options and sold 1,420 common shares on August 3, 2026. The options converted at $209.25 per share into common stock, followed by open-market sales at $309.22 and $309.2311 per share.

At what prices did Labcorp Holdings (LH) insider Peter J. Wilkinson sell his shares?

He sold Labcorp common stock at $309.22 and $309.2311 per share on August 3, 2026. These open-market transactions followed the exercise of 1,338 non-qualified stock options that had a lower exercise price of $209.25 per share.

How many Labcorp (LH) options did Peter J. Wilkinson exercise and what was the strike price?

Wilkinson exercised 1,338 non-qualified stock options with an exercise price of $209.25 per share. The grant was issued under Labcorp's Amended and Restated 2016 Omnibus Incentive Plan and is now fully exercised, eliminating the remaining option balance from this specific award.

What does the Labcorp (LH) Form 4 indicate about Peter J. Wilkinson’s remaining option position from this grant?

The Form 4 shows 0 options remaining from this particular non-qualified stock option grant after exercising 1,338 options. The reported options had an original expiration date of February 1, 2031 and are now fully converted into common stock.

How many Labcorp (LH) common shares did Peter J. Wilkinson sell relative to the options he exercised?

He exercised 1,338 options and sold a total of 1,420 common shares. This total includes 1,338 shares corresponding to the exercised options and an additional 82 shares, all sold in open-market transactions on August 3, 2026.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wilkinson Peter J

(Last)(First)(Middle)
231 MAPLE AVENUE

(Street)
BURLINGTON NORTH CAROLINA 27215

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/03/2026S82D$309.221,770.2194D
Common Stock08/03/2026M1,338A$209.253,108.2194D
Common Stock08/03/2026S1,338D$309.23111,770.2194D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-qualified Stock Options(1)$209.2508/03/2026M1,338(2)02/02/2022(3)02/01/2031Common Stock1,338$00D
Explanation of Responses:
1. Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
2. Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
3. The options vested in three equal annual installments beginning on the date reflected in this column and are now fully exercisable.
/s/ Kathryn W. Kyle, Attorney-in-Fact for Peter J. Wilkinson08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)